Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ure ido]-phenyl}-ethyl)-carbamic acid2-cyano-1-ethyl-ethyl ester

Details for Australian Patent Application No. 2005228859 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Cui, Yong; Nyce, Philip L.; Blythe, Todd A.

Agent Cullen & Co

Pub. Number AU-A-2005228859

PCT Pub. Number WO2005/095333

Priority 60/555,553 23.03.04 US

Filing date 22 March 2005

Wipo publication date 13 October 2005

International Classifications

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

C07C 275/40 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095333 Priority application(s): WO2005/095333

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228861-Process for surface modifications of particles of TiO2 and other ceramic materials

2005228856-Pyrazole compounds and uses related thereto